The Pharmacy And Poisons Board Of Hong Kong Is Responsible For Licensing And Regulatory Control Of Manufacturers Of Pharmaceutical Products. The GMP Inspection Team Of The Drug Office Provides Executive Support To The Pharmacy And Poisons Board By Assessing New Applications Or Applications For Change Of Particulars And Conducting Inspections, In Order To Make Recommendations To The Pharmacy And Poisons Board For Decision On Licensing Issues.
The GMP Inspection Team Is Part Of The Traders Licensing And Compliance Division Of The Drug Office Of The Department Of Health And Consists Of The Manufacturers Regulatory Unit (MRU) And Manufacturing Quality Assurance Unit (MQAU). The GMP Inspection Team Is Responsible For Assessing The Compliance Of Pharmaceutical Manufacturers With The Conditions Of The Relevant License, The Laws Of Hong Kong And The GMP Guide Issued By The Pharmacy And Poisons Board Of Hong Kong.
Good Manufacturing Practice Is That Part Of Quality Assurance Which Ensures That Pharmaceutical Products Are Consistently Produced And Controlled To The Quality Standards Appropriate To Their Intended Use And As Required By The Marketing Authorization Or Product Specification.